(Reuters) - Drugmakers, device companies and health insurers all got some good news when Democrats in the U.S. House of Representatives released changes to healthcare reform legislation on Thursday.Hefty taxes on those three industries were delayed by at least a year, among other adjustments to the bill that seeks to overhaul the nation's healthcare system.Following are some of the winners and losers for the healthcare industry based on the reconciliation bill the House is considering along with the Senate's bill. A vote is expected on Sunday.WINNERSBRANDNAME DRUGMAKERS
(Reuters) - Drugmakers, device companies and health insurers all got some good news when Democrats in the U.S. House of Representatives released changes to healthcare reform legislation on Thursday.
Hefty taxes on those three industries were delayed by at least a year, among other adjustments to the bill that seeks to overhaul the nation's healthcare system.
Following are some of the winners and losers for the healthcare industry based on the reconciliation bill the House is considering along with the Senate's bill. A vote is expected on Sunday.
WINNERS
BRANDNAME DRUGMAKERS
March 20 (Bloomberg) -- Republican Senator Orrin Hatch said Democrats in the U.S. House of Representatives are "nuts" to think tomorrow's vote on health-care legislation will resolve the issue. If the measure passes, Senate Republicans have enough votes on at least two points of order to alter the measure and send it back to the House for a second round of votes, Hatch said in an interview on Bloomberg Television's "Political Capital with Al Hunt," airing this weekend. "If those people think they're only going to vote on this once, they're nuts," Hatch said as House Democratic leaders rounded up support before the scheduled vote on President Barack Obama's top domestic priority. The senator from Utah also said the approach Democrats are using to pass the legislation in the House may be unconstitutional because the House and Senate aren't voting on "exactly the same language."
March 20 (Bloomberg) -- Republican Senator Orrin Hatch said Democrats in the U.S. House of Representatives are "nuts" to think tomorrow's vote on health-care legislation will resolve the issue.
If the measure passes, Senate Republicans have enough votes on at least two points of order to alter the measure and send it back to the House for a second round of votes, Hatch said in an interview on Bloomberg Television's "Political Capital with Al Hunt," airing this weekend.
"If those people think they're only going to vote on this once, they're nuts," Hatch said as House Democratic leaders rounded up support before the scheduled vote on President Barack Obama's top domestic priority.
The senator from Utah also said the approach Democrats are using to pass the legislation in the House may be unconstitutional because the House and Senate aren't voting on "exactly the same language."
CSPAN, 00:46:00, 20 March 2010 Diversity is the key to economic and political evolution.
